GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026

GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026

YONGIN, South Korea, March 24, 2026 /PRNewswire/ -- GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in...

Traditional Japanese Tea Ceremony Room "Sho-fu-an" within Keio Plaza Hotel Tokyo to Resume Operations from Monday, April 6, 2026

Traditional Japanese Tea Ceremony Room "Sho-fu-an" within Keio Plaza Hotel Tokyo to Resume Operations from Monday, April 6, 2026

- Certified Japanese Tea Ceremony Master to Provide Tea Ceremony and "Tencha" Tea Preparation Experiences with English Commentary for Small Groups of Guests - TOKYO, March 24, 2026 /PRNewswire/ -- Keio Plaza Hotel Co., Ltd. will resume operation of...

Digital infrastructure powers Xiong'an, China's 'city of future'

Digital infrastructure powers Xiong'an, China's 'city of future'

BEIJING, March 23, 2026 /PRNewswire/ -- A report from People's Daily: Photo shows the Xiong'an Urban Computing Center. (People's Daily/Lei Sheng) As night falls, a deep-blue "eye" gazes into the distance. Located in the western part of the Rongdong...

KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF

KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF

Revenue amounted to approximately RMB2057.92 million, and gross profit amounted to approximately RMB1478.78 million, representing a year-on-year increase. R&D Expenses was approximately RMB1319.68 million. Loss for the period was RMB381.97...

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer

SUZHOU, China, March 24, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in the Phase III clinical study (KN026-007) of HER2 bispecific antibody Anbenitamab (KN026) in combination...

LEIFRAS Co., Ltd. Releases Two Business Introduction Videos Visualizing "Community Transfer of Club Activities" and "Sports Therapy"

LEIFRAS Co., Ltd. Releases Two Business Introduction Videos Visualizing "Community Transfer of Club Activities" and "Sports Therapy"

Bringing to Life How Schools, Homes, and Communities Are Changing Across Japan Through Real Insights from the Field TOKYO, March 24, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business...

2026 CIFM / interzum guangzhou Ushers in a New Era of Smart Furniture Manufacturing

2026 CIFM / interzum guangzhou Ushers in a New Era of Smart Furniture Manufacturing

GUANGZHOU, China, March 23, 2026 /PRNewswire/ -- From 28 to 31 March 2026, CIFM / interzum guangzhou, co-organized by Koelnmesse GmbH and China Foreign Trade Centre Group, Ltd., will return to Canton Fair Complex in Guangzhou, China. Under the core...

Daiso to Enhance Demand Forecasting and Store and DC Ordering with RELEX

Daiso to Enhance Demand Forecasting and Store and DC Ordering with RELEX

Leading Japanese discount retailer selects RELEX forecasting and replenishment to improve inventory accuracy and operational efficiency across domestic network TOKYO, March 23, 2026 /PRNewswire/ -- RELEX Solutions announces Daiso Industries Co.,...

Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair

Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair

BEIJING, March 20, 2026 /PRNewswire/ -- The 2026 London Book Fair drew to a close on 12 March at Olympia London. As one of the world's most influential publishing gatherings, the fair provided a key global platform for Chinese publishers to showcase...

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs

SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had been invited to give a speech at the RNA Leaders Europe Conference in Vienna,...

  • 1
  • ...
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • ...
  • 151
  • menu
    menu